BETA-LACTAMS Penicillin Pen G Crystalline
50-100 mkD q6 100,000-200,000 ukD q12 50,000-100,000 ukD q8/q12 (< 7days) 75,000-150,000 ukD q6-q12 (>7days) 500,000 u/K sinl! d"s! (!a#ly sy$%ilis) 50,000 u/K ma& d"s! 2.4 ' u/d"s! (sy$%ilis) 50 mkD q6
Benzathine Penicillin 1.2 m.u., 2.4 m.u/vial
Sumapen Phenoxymethyl penicillin 125/5 200,000 u/5m 250/5 400,000 u/5m
CEP%AL&SP&'$S )$'ST GEE'AT$& Ce*alexin
25-50 mkD q6 (ma& 4m/D)
D* 100m/m +* 125m/5m, 250m/5m * 250m, 500m, 1m
Ce*azolin
20-50mkD q6-q8 100mkD (s!v!#! in!i"n)
* 500m, 1m
SEC&+ GEE'AT$& Ce*aclor
Ampicillin D* 125m/1.25m +* 125m/5m, 250m/5m * 250m, 500m * 125m, 250m, 500m, 1m
Ampicillin-Sulbactam Sultamicillin (nasyn!
50-100 mkD q6/q8 (n!"na!s) q6/q8 (n!"na!s) 100-200 mkD q4/q6 100-150 mkD q8-q12 (m!niniis n!"na!s) 200-400 mkD q4/q6 (m!niniis) 100-200 mkD q8 1.5-12m/day 50mkD q12 (<0k) 2.25m (sinl! d"s!, "n"##%!a)
+* 250m/5m * 75m, 750m * 750m, 1.5m
Amoxicillin
0-50 mkD q8
D* 100m/m +* 125m/5m, 250m/5m * 250m, 500m * 1m
Amoxicillin-Cla"ulanic Aci# (Co-Amoxicla"!
20-40 mKD q8
D* 50m/m +* 125m/5m, 250m/5m * 250m, 500m
Ce*uroxime
Ce*oxitin
80-160 mkD q4-q6 (ma& 12m/D) 20-40 mkD (inans)
* 500m, 1m
T%$'+ GEE'AT$& Ce*tazi#ime
100-150 mkD q8
* 250m, 500m, 1m, 2 m
Ce*triaxone
50-100 mkD D
* 250m, 500m, 1m, 2m
Ce*otaxime
100-200 mkD q4-q6
* 250m, 500m, 1m 0-50mkD q8 $" 50-100mkD q8
+* 156.25/5 (125), 228.5/5 (200), 12.5/5 (250), 457/5 (400) * 75m, 625m * 600m (500), 1.2m (1000)
Ce*ixime
-8 mkD q12
D* 20m/m +*100m/5m * 100m, 200m
)&'T% GEE'AT$& Ce*epime
50mkD q8-12 & 10 days 500m-1m q12 (>12 y/")
* 500m, 1m, 2m
Amoxicillin-sulbactam (ltramox!
0-50mkD q8 $" 50-100mkD q8
+* 250m/5m * 500m * 500/250m, 1000/500
TET'AC,CL$E Tetracycline
25-50 mkD
* 250m, 500m
+oxycycline
4.4 mkD 2.2 mkD
* 100m
Piperacillin-Tazobactam * 4m/500m, 2m/250m
Aztreonam * 1m
Meropenem * 500m, 1m
$mipenem * 500m
200-00 mkD q6 150-00 mkD q8 (<6m"n%s) 50 mkD q6-q8 (%ild#!n) 0 mkD q6-q8 (13k-2y/") 20 mkD q12 (s!$i) 40 mkD q12 (m!ninii) 15 mkD (ma& 2m/D) 50 mkD "# 1-2 m q6-q8 (ma& 4m/D adul)
)L&'&$&L&ES Cipro*loxacin
0-50 mkD q8-q12 (ma& 1m)
Le"o*loxacin
+* 200m/5m * 250m, 500m * 500m
10 mkD & days 10 mkD 1s day, day, 2 mkD 2nd -5% day
Chloramphenicol
AT$)GALS )luconazole
12 mkD D 6 mkD 'D
* 50m, 100m, 150m 200m * 2m/m
:etoconazole
5 mkD D (<15k) 100 mkD D (>20k) 200 mkD D (>0k) 10 mkD
* 200m
Griseo*ul"in * 125m, 500m
Amphotericin B
AM$&GL,C&S$+ES Ami.acin
15 mkD q12 (ma& 1m/D)
+* 125m/5m, 250m/5m * 250m, 500m * 50m/m
Azithromycin
8mkD q12 (250m ma&)
* 250m, 500m * 5m/m inusi"n
15 mkD (D) * 50m/m, 125m/m, 250m/m 10 mkD q12 ('D) 5-8 mkD q8-q12 Gentamycin * 40m/m, 80m/2m 6-8 mkD D eltilmicin * 50m/m, 75m/m
D* 100m/2.5m +* 200m/5m, 400m/5m,
Clarithromycin
7.5-15 mkD
* 250m, 500m * 2m/m inusi"n
MAC'&L$+ES Erythromycin
'D* 0.5-1 'D* 0.5-1 mkD D
&T%E' AT$BACTE' AT$BACTE'$ALS/AT$B$&T$CS $ALS/AT$B$&T$CS
Co-trimoxazole
Clin#amycin +* 75m/5m #anul!s * 150m, 00m * 150m/m + in 0mins
1ancomycin * 500m
11 mkD & d"s!s D
+* 125m/5m * 125m
Metroni#azole
Meben#azole
200 - 500 mkD D sinl! d"s!
+* 20m/m, 50m/m * 100m, 500m
AT$TBE'CL&S$S 'i*ampicin ('!
10-20 mkD D :
D* 100m/5m +* 200m/5m * 150m, 00m, 450m
$soniazi# (%!
10-20 mkD D :
+* 200m/5m * 75m, 100m, 200m, 00m, 400m
* 275m, 400m, 800m
Streptomycin (S!
+* 125m/5m * 500m * 5m/m
B0 5mkD q8-12 $" B0 5mkD $n*ant/chil#0 15-25mkD q6 20-0 mkD q6 234556 (5-78.s!* (5-78.s! * 15mkd"s! D 934556 (5-38.!* (5-38.!* 20mkd"s! D (3-78.s!** 0mkd"s! D (3-78.s! $n*ant/chil#0 20mkd"s! q8 60mkD q8 1- %# inusi"n 0-50 mkD q8-q12 15 mkD D, 7.5 mkD q8
AT$1$'ALS Acyclo"ir +* 200m/5m * 200m, 400m, 800m * 250m
Amanta#ine * 100m, 250m * 500m
10-20 mkD q6 200m 5& daily (adul, %ild#!n, > 2 y/") adul d"s! (%ild#!n < 2 y/") 5-9 mkD q12 (<8y/") 100-200m (>8 y/" n" >200m/D) >200m/D)
Methisoprinosol ($soprinosine! 50 mkD q6-q8 15-0 mkD D
+* 250m/5m * 400m, 500m
Ethambutol (E!
5-8 mkD q12
+* 40m/5m (200), 80m/5m (400), 160m/5m (800) * 400m/80m, 800m/160m
AT$PA'AS$T$C Pyrantel Pamoate
50-100 mkD q6-q8 50 mkD q6 25 mkD q6 (n!"na!s)
+* 125m/5m * 250m, 500m * 1m
* 5m/m, 50m/10m
Pyrazinami#e (;!
20-40 mkD q12 50-100 mkD q8
+* 125m/5m, 250m/5m * 250m, 500m * 750m, 1.5m
15 mkD D 5-25mKD (<2 m"n%s) 10 mkD D ; 48 "# D
+* 250m/5m * 500m
AALGES$C A+ AT$P,'ET$CS Paracetamol
10-15 mkd q4
D* 100m/m +* 120m/5m, 250m/5m * 80m, 500m * 150m/m, 00m/2m +u$$* 125m, 250m
Me*enamic Aci#
+* 2m/5m * 4m 0m/a= 6.5 mkd q6
6-8 mkd q6
D* 100m/2.5m +* 100m/5m, 200m/5m * 200m, 800m
Aspirin
60-80 mkD ?@D* 100mkD (1s 23ks), 75 mkD (43ks) :ni-inlamma"#y* 60-90 mkD Ka3asaki* 80-100mkD q6 1-2 mkD & (D:)
* 80m, 100m, 25m
$n#omethacin
+y#u$ (15m/5m)
nan d#"$s (6m/m
Carbocisteine +y#u$ (100m/5m)
+y#u$ (250m/5m)
* 100m
aproxen
5-7 mkD q8-q12 (>2y/")
* 275m, 550m
albuphine
0.1-0.2 mkd ',
D#"$s (50m/m)
* 10m/m
Mi#azolam
0.2 mkd
* 15m * 1m/m, 5m/m
Er#osteine
Meperi#ine Morphine
6 mkD/ 0.5-1 mkD 0.1-0.2 mkd q6 (ma& 15m)
EP%'& / 'EAL ME+$CAT$&S Pre#nisone
ephrotic0 >40m/day %ypoalbuminemia0 <2.5m/d 60mkD & 4-6 3!!ks %!n 40mkD (am) & 2- m"n%s Alternate #ay #ose $* steroi# resistant0 A2 $#"!in q8 3!!ks $* steroi# #epen#ent0 #!la$s! 3i%in 28 days )re=uent relapse0 #!la$s!> 12& $!# m"n% 2- mkD sinl! d"s! 8-12 3!!ks
Cyclophosphami#e
+* 175m/5m * 00m
Procaterol (Meptin!
* 10m, 0m, 60m, 100m * 10m/m
+* 5m/m * 25m, 50m
Salbutamol < Guai*enesin
Acetylcysteine ()luimucil! +a%!* 100m, 200m +* 100m/5m (!!#v!s!n)* 600m
Guai*enesin
Phenylpropanolamine
+y#u$ (12.5m/5m)
E'&LEPT$CS > AT$-C&1LSATS * 5m, 10m/a= * 5m/m, 10m/m
Carbamazepine (Te6retol! Mannitol 45@ Phenobarbital 20m/5m #ain 1C60m * 15m, 0m, 60m, 90m * 10m/m
Phenytoin (+ilantin!
0.2-0. mkD Max #ose0 2?y/o0 5m 9?y/o0 10m +rip0 50m (10) A 250 0.9 B++ " #un a 1/k/%# 27 y/o0 20-60m/day in =y 20-60m D 7y/o0 100m/day in =y 100m 3!!kly 10-20 mk 'D 2.5-5 /k q6-q8 L+0 10-20 mkd M+0 5 mkD q12 Max0 1-2ms (00m) 10-20 mkd D 5 mkD q12 'D Max0 1 m 15mkD (D) D/D 20mKD q8 ('D)
+* 0m/5m, 125m/5m * 50m/m
1alproic Aci# +* 250m/5m * 100m/m
STE'&$+S Betamethasone * 500m * 1m, 2m +examethasone * 500m, 750m, 4m ("#! a=) * 2m/m, 4m/m, 5m/m %y#rocortisone * 20m * 100m, 200m, 250m, 400m, 500m Pre#nisone +* 10m/5m * 5m, 20m
0.0178-0.25 mkD q6-q8 Max0 9m/D 0.5-1mkD "# 1 mkD q4-q6 "# !#!=#al !d!ma 0.2-0.5 mkd "# =a!#ial m!niniis 5m 10m q6 (adul d"s!) 10-15 mkD D, 4-6 mkD q6-q8 'D (as%ma) -4 mkD (D!nu!)
Promethazine %Cl (Phener6an!
1m/k '
* 25m/m
)exo*ena#ine
120m D
* 120m, 180m
Chlorphenamine maleate +* 2m/5m * 4m * 10m/m
23y/o0 2.5m D 3-y/o0 2.5-5m D 9y/o0 5m D -34y/o0 a= D A#ult0 1 a= D "# 2 s$ D
A6e 1-2 y/" 7-12 m"s 4-6 m"s 1- m"s 2-6 y/"
AT$-%$STAM$ES
+ose 1 a= D a= D 10m D 5m D-D 2.5m D 1.25m D 1m D 0.5m D +ose 5m D 10m D 15m D 2.5m D 5m D 7.5 m D 0.m D 0.6m D 0.9m D 1.2m D 10m D 5m D 5m D 0.25mKD D-D 5m "# 25m/a= D-D 20m "# 50m/a= D-D 10m D, 1 a$ D-D 1s$ D -1s$ D 100m D-;D 200m D-D, 600mD
5m D-;D 5-10m D-;D 1-2a$ D-;D +ose 1m ;D 0.75m ;D 0.5m ;D 0.25 m ;D 2.5m ;D
(CONT.) 1m D
Cetirizine
mons-3y/o
D* 2.5m/m, 10m/m +* 1m/m, 5m/5m * 10m
3-4 y/o
2.5 m D (5 d#"$s D) 1m D "# D
4-? y/o
a= D "# a= D 5m D "# 2.5m D
-34 y/o
a= D 10m D "# 5m D
+iphenhy#ramine +* 12.5m/5m * 25m, 50m * 50m/m
%y#roxyzine %Cl +* 2m/m * 10m, 25m
Lorata#ine +* 1m/m, 5m/5m * 10m
34 y/o > 1 a= D 1-2 m/k (max 100m/d"s!) -5 mkD 4- y/o0 2.5 m q6/q8 -34 y/o0 5m q6/q8 1-2 mkD q12 A#ult0 25m D -;D 3-4 y/o0 2.5m D 4-34 y/o0 25.60 5m 95.60 10m 934y/o0 1 a= D
'ESP$'AT&', ME+$CAT$&S > B'&C%&+$LAT&'S Aminophylline 5m/m
1-2 mkD q12 +: & 60 mkD (B!$%#"i)
AT$-%$STAM$ES
A6e >10y/" 5-10 y/" >10y/" 6-10 y/" 2-5 y/" 1-2 y/" 7-12 m"s <6 m"s A6e 2- y/" 4-7 y/" 8-12 y/" 2- y/" 4-7 y/" 8-12 y/" <2 m"s -6 m"s 7-12 m"s 1-24 m"s >0k 20-0k 15-19k < 5y/" >6y/" :dul >12 y/" 6-12 y/" 2-6 y/" %ild#!n :dul
6-12 y/" :dul*
+* 100m/5m * 200m D#"$s (6.25m/m)
+iazepam
0.2-0. mkD >12 y/"* 5m D "# 1 a= D
* 10m/m
Ambroxol
+* 50m/5m * 250m, 500m
$bupro*en
C&G% A+ C&L+S ME+$CAT$&S Chlorpheniramine maleate
%y#rocortisone (SoluCorte*! * 100m, 200m, 250m
Salbutamol
-5 mkD (0.6-0.9mk/%#) L+0 -6m/k & 20-0mins M+0 2mkd q8 M+0 o 3-Dy/o0 0.8 1-1.2%# o D-34 y/o0 0.7 0.9%# o 4-3 y/o0 0.5 q6-8 Example0 20k C (3 & d"s!) / $#!$a#ai"n (20 & 5) / 5 C 20 + as D (20 & 2) / 2 C 8 + q8 as 'D 10mkd D, 4-9mkd M+ 10-20 mkD L+ 5-6 mkD q8 'D (as%ma) -5m mk/d"s! 0.15-0.0 mkD q6
+* 2m/5m * 2m
Terbutaline 1.5m/5m sy#u$, 5m/2min!=ul!
0.075 mkd q6 0.01 mkd (ma& 0.5)
GAST'& ME+S A+ AT$-LCE'S Al M6 (&%! (Maalox! Al M6 (&%! < #imethicone Bisaco#yl (+ulcolax! * 5m +u$$* $!dia 5m, adul 10m
%yoscine--butylbromi#e (Buscopan!
Al#actone )urosemi#e
34 y/o0 1-2 a= -5& a day, max 355m6/#ay $n*ants > youn6 chil#ren0 0.-0.6 mkD
* 250 m
* 10m * 20m
Cimeti#ine
5 mkD q6 D, 5-10 mkD q6
* 200m, 400m * 100m/m, 150m/m
'aniti#ine
1 mkD q8 A#ult0 150m D "# 00m D
* 75m, 150m, 00m * 25m/m
+icyclo"erine D*5m/m +* 10m/5m * 10m
+omperi#one
+*218/5m *200m
Prozinc
2 mos0 10m 9 mos0 20m
D* 0.5-1m D (1mL= 10mg elemental Zn) +* 2.5-5m D (5mL =20mg elemental Zn)
'aceca#otril (%i#rasec!
AT$-%,PE'TES$1ES/CA'+$AC ME+S
2D.60 10m/sa%! D D-3.60 10m/2sa%! D 3-4.60 0m/sa%! D 94.60 0m/2sa%! D A#ults0 100m/a$ D
0.5-1 mkD q8 5m #a$id $us% 0.15-0. mkd"s! q4-6 1-mkD q4-6 $"
* 10m, 25m, 50m * 20m
i*e#ipine
0.25 mkD q4-q6
* 5m, 10m
+i6oxin Amio#arone Ca Gluconate
2 mos0 1 s$ D 9 mos0 1s$ D
20 mkD 250 75 m/day
Captopril +iazoxi#e %y#ralazine
0.2m k/d"s! q8
*20m,40m * 40m
itro*uroxi#e (Erce*uryl!
Acetazolami#e (+iamox!
Amlo#ipine
1 vial D & 5 days 2m/k/d"s! q6 0.6-0.7 mkD D
2-.5 mkD 1 mkd q6-12
* 20,40,60m * 20m/m
mons-4 y/o0 0.5-1m ;D 4-? yo0 2.5-5m ;D -34 y/o0 5 m ;D
D* 5m/m +*1m/m 5m/5m *10m
Erce*lora Lactulose &meprazole
+$'ET$CS
2-4 a=s 20 mins $#! m!al and @+ 2-4 s$ "# a= ;D -34 y/o0 5-10 m 934 y/o0 10-15 m
5m/a= D-D
* 5m, 10m
Propranolol
1-2 mkD q6-12
* 5m, 10m
* 100m/m
Ca Chlori#e Ca Carbonate Aspirin
0.05 m/k /' 10mkd 0min-1%# D 25 mkd q8 Dilu! 1 m n 2 m s!#il! 3a!# 0./k (27m a/) 0-50 mkd q8 65 mkD '%+0 o 3st 4 8ee.s0 100mkD o 7 8ee.s0 75mkD Anti-in*lammatory0 60-90 mkD :a8asa.i0 100 mkD,q6 (-! )e"er0 8-10 mkDs
MLT$1$TAM$S 2 months -34 months 3-4 y/o 4- y/o -34 y/o 934 y/o
0.m D 0.6m D 1.2m D 2.5m D 5m D 20m "# 1 a= D
